Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorİlhan, Çağrı
dc.contributor.authorÇıtırık, Mehmet
dc.contributor.authorUzel, Mehmet Murat
dc.contributor.authorKızıltoprak, Hasan
dc.contributor.authorTekin, Kemal
dc.date.accessioned2021-03-18T11:00:47Z
dc.date.available2021-03-18T11:00:47Z
dc.date.issued2020en_US
dc.identifier.issn0004-2749
dc.identifier.issn1678-2925
dc.identifier.urihttps://doi.org/10.5935/0004-2749.20200051
dc.identifier.urihttps://hdl.handle.net/20.500.12462/11236
dc.descriptionUzel, Mehmet Murat (Balikesir Author)en_US
dc.description.abstractPurpose: To investigate the usefulness of systemic inflammatory markers [i.e., white blood cell and platelet counts, mean platelet volume, and their ratios] as diagnostic markers of the pathogenesis of diabetic macular edema. Methods: The study cohort included 80 diabetic macular edema patients (40 with diabetic retinopathy and 40 without) and 40 healthy age- and sex-matched controls. Neutrophil, lymphocyte, monocyte, and platelet counts, and the mean platelet volume were determined from peripheral blood samples, and the monocyte/lymphocyte, platelet/lymphocyte, and mean platelet volume/lymphocyte, and neutrophil/lymphocyte ratios were calculated and compared among groups. Results: The mean neutrophil/lymphocyte ratio of the diabetic macular edema and non-diabetic macular edema groups was higher than that of the control group, and the value of the diabetic macular edema group was higher than that of the non-diabetic macular edema group (p<0.001 in diabetic macular edema vs. control, p=0.04 in non-diabetic macular edema vs. control, and p=0.03 in diabetic macular edema vs. non-diabetic macular edema). A neutrophil/lymphocyte cutoff value of >= 2.26 was identified as an indicator of the pathogenesis of diabetic macular edema with a sensitivity of 85% and specificity of 74%. The mean platelet volume of the diabetic macular edema group was higher than those of the non-diabetic macular edema and control groups, while those of the non-diabetic macular edema and control groups were similar (diabetic macular edema vs. non-diabetic macular edema, p=0.08; diabetic macular edema vs. control, p=0.02; and non-diabetic macular edema vs. control, p=0.78). All other parameters were similar between groups (all p>0.05). Conclusion: The neutrophil/lymphocyte ratio and mean platelet volume of the diabetic macular edema group were higher than those of the non-diabetic macular edema and control groups. A neutrophil/lymphocyte ratio cutoff value of >= 2.26 was identified as an indicator of the pathogenesis of diabetic macular edema with high sensitivity and specificity. Moreover, the neutrophil/ lymphocyte ratio of the non-diabetic macular edema group was higher than that of the control group.en_US
dc.language.isoengen_US
dc.publisherConsel Brasil Oftalmologiaen_US
dc.relation.isversionof10.5935/0004-2749.20200051en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectMacular Edemaen_US
dc.subjectDiabetic Retinopathyen_US
dc.subjectMean Platelet Volumeen_US
dc.subjectLymphocyte Counten_US
dc.subjectNeutrophilsen_US
dc.subjectInflammationen_US
dc.titleThe usefulness of systemic inflammatory markers as diagnostic indicators of the pathogenesis of diabetic macular edemaen_US
dc.typearticleen_US
dc.relation.journalArquivos Brasileiros de Oftalmologiaen_US
dc.contributor.departmentTıp Fakültesien_US
dc.contributor.authorID0000-0002-7420-8934en_US
dc.identifier.volume83en_US
dc.identifier.issue4en_US
dc.identifier.startpage299en_US
dc.identifier.endpage304en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess